One-Year Follow-Up of Cystic Fibrosis Patients Who Cannot Reach the Modulator Therapies Although Having Indications: What are Their Losses?
S Uytun, Şehrinaz Polat, Satı Özkan Tabakçı, G Cinel et autres
Objectives: It is shown that modulatory therapies(MT) in cystic fibrosis(CF) positively affect pulmonary function tests(PFT) parameters,patients’ weight gain, decreasing lung infections and lung-related deaths and improving quality of life. Many CF patients cannot reach MT in our country. This study aims to …
tr (code pays fourni par la source)